Biora Therapeutics, Inc.
BIORQ
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -89.94% | -41.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -89.94% | -41.33% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -89.94% | -41.33% | |||
| SG&A Expenses | 26.77% | -7.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.96% | 0.29% | |||
| Operating Income | -2.79% | -1.74% | |||
| Income Before Tax | -447.95% | 254.50% | |||
| Income Tax Expenses | 34.33% | -239.58% | |||
| Earnings from Continuing Operations | -443.67% | 254.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -384.64% | 254.33% | |||
| EBIT | -2.79% | -1.74% | |||
| EBITDA | -2.81% | -1.72% | |||
| EPS Basic | -378.34% | 226.58% | |||
| Normalized Basic EPS | -276.70% | 232.99% | |||
| EPS Diluted | -1,322.28% | 75.23% | |||
| Normalized Diluted EPS | -467.15% | 164.01% | |||
| Average Basic Shares Outstanding | 2.26% | 21.92% | |||
| Average Diluted Shares Outstanding | -50.78% | 153.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||